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1. INTRODUCTION {#mgg3971-sec-0005}
===============

Liver cancer ranks the fourth place of all newly identified cancer cases but the third place of cancer‐related deaths in China (Chen et al., [2016](#mgg3971-bib-0006){ref-type="ref"}). Hepatocellular carcinoma (HCC) alone is reported to represent about 75%--85% of all liver cancer cases (Bray et al., [2018](#mgg3971-bib-0004){ref-type="ref"}). Exposure to aflatoxin B1 (AFB1) is considered as a trigger for the initiation of HCC (Llovet et al., [2016](#mgg3971-bib-0020){ref-type="ref"}). However, genes alteration in primary human hepatocytes after AFB1 exposure remains to be elucidated.

Aflatoxin B1 is believed to be transformed to AFB1‐8,9‐epoxide by a specific P450 enzyme and then interact with cellular proteins or DNA to increase the risk of developing into HCC (Groopman, Kensler, & Wild, [2008](#mgg3971-bib-0012){ref-type="ref"}). It has also been recognized that AFB1 exposure will cause persistent epigenetic changes (Ferreira et al., [2019](#mgg3971-bib-0010){ref-type="ref"}; Rieswijk et al., [2016](#mgg3971-bib-0021){ref-type="ref"}). For example, the mutation of *P53* (191170), a well‐characterized tumor suppressor gene, is often found in tissues or cells encountered with AFB1, which will lead to the loss function of *P53* (Shen & Ong, [1996](#mgg3971-bib-0023){ref-type="ref"}). Moreover, it was found that exposure of AFB1 will cause aberrant methylation status in genes including *RUNT RELATED TRANSCRIPTION FACTOR 3* (600210), *LONG INTERSPERSED NUCLEAR ELEMENT 1* (151626), and so on to initiate carcinogenesis (Wang et al., [2017](#mgg3971-bib-0024){ref-type="ref"}). In addition, specifically altered microRNA (miRNA) including *MIR‐4651* and *MIR‐34a* (611172) have been observed in AFB1‐induced hepatotoxicity (Wu et al., [2017](#mgg3971-bib-0025){ref-type="ref"}; Zhu et al., [2015](#mgg3971-bib-0027){ref-type="ref"}). However, genes altered after AFB1 exposure in human hepatocytes remain to be elucidated.

MicroRNAs are endogenous noncoding RNAs with the length of 18--25 nucleotides, which can directly regulate gene expression through 3'‐untranslated region binding (Bartel, [2009](#mgg3971-bib-0002){ref-type="ref"}). It has been reported that miRNAs are crucial modulators for various cellular behaviors including cell growth, invasion, apoptosis, and so on (Gandellini, Doldi, & Zaffaroni, [2017](#mgg3971-bib-0011){ref-type="ref"}; Jafri, Al‐Qahtani & Shay, [2017](#mgg3971-bib-0014){ref-type="ref"}). Studies focusing on the investigations of abnormally expressed miRNAs in human cancers revealed that miRNA has crucial roles in tumorigenesis (Gandellini et al., [2017](#mgg3971-bib-0011){ref-type="ref"}; Jafri et al., [2017](#mgg3971-bib-0014){ref-type="ref"}).

Here, we are interested to investigate abnormally expressed miRNAs after AFB1 exposure with the aim to understand key miRNAs that can trigger HCC carcinogenesis. Therefore, in this study, we investigated dysregulated miRNAs in human hepatocytes treated with AFB1. Finally, novel miRNA‐message RNA (mRNA) regulatory networks associated with HCC onset were constructed.

2. MATERIALS AND METHODS {#mgg3971-sec-0006}
========================

2.1. Microarray dataset {#mgg3971-sec-0007}
-----------------------

GSE71540, obtained from Gene Expression Omnibus (<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE71540>), is a miRNA expression profile dataset submitted by Linda Rieswijk. This dataset contained data from primary human hepatocytes subjected to 1 µM of AFB1 for 5 days followed by a 3 days wash‐out period or not.

2.2. Identification of differentially expressed miRNAs {#mgg3971-sec-0008}
------------------------------------------------------

GEO2R, an algorithm based on R language limma package, was employed to analyze differentially expressed miRNAs (DEMs) in this dataset. Cut‐off criteria were set as *p* \< .05 and \|log2 fold‐change\| ≥ 1.5. Volcano plot was established using the plug‐in tool at SangerBox (<http://sangerbox.com>) to help us identify the overlapping genes. Heatmap was also built by plug‐in tool at SangerBox (<http://sangerbox.com>) to give a direct presentation of the expression status of genes in different samples.

2.3. Identification of target genes for DEMs {#mgg3971-sec-0009}
--------------------------------------------

Targets of these identified DEMs were predicted at five miRNA target prediction websites including TargetScan V_7.2 (<http://www.targetscan.org/vert_72/>, Agarwal, Bell, Nam, & Bartel, [2015](#mgg3971-bib-0001){ref-type="ref"}), miRDB (<http://www.mirdb.org/miRDB/index.html>, Liu & Wang, [2019](#mgg3971-bib-0018){ref-type="ref"}), PITA (<https://genie.weizmann.ac.il/pubs/mir07/mir07_data.html>, Kertesz, Iovino, Unnerstall, Gaul, & Segal, [2007](#mgg3971-bib-0016){ref-type="ref"}), miRanda (<http://www.microrna.org/microrna/home.do>, Betel, Wilson, Gabow, Marks, & Sander, [2008](#mgg3971-bib-0003){ref-type="ref"}), and miRTarBase (<http://mirtarbase.mbc.nctu.edu.tw/php/index.php>, Chou et al., [2018](#mgg3971-bib-0007){ref-type="ref"}). Target predicted by at least three algorithms were selected for the following studies.

2.4. Functional analyses {#mgg3971-sec-0010}
------------------------

Database for Annotation, Visualization and Integrated Discovery (DAVID; <https://david.ncifcrf.gov>, Jiao et al., [2012](#mgg3971-bib-0015){ref-type="ref"}) was employed to perform gene ontology (GO) including cellular component (CC), molecular function (MF), and biological process (BP) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis with the purpose of understanding the biological functions of these genes. Parameter *p* \< .01 was used as threshold.

2.5. Gene expression level validation {#mgg3971-sec-0011}
-------------------------------------

The expression level of DEMs and their target was validated at StarBase (Li, Liu, Zhou, Qu, & Yang, [2014](#mgg3971-bib-0017){ref-type="ref"}).

2.6. miRNA‐mRNA regulatory network construction {#mgg3971-sec-0012}
-----------------------------------------------

miRNA‐mRNA regulatory network related to the onset of HCC was visualized using CytoScape V_3.6.0 software (Shannon et al., [2003](#mgg3971-bib-0022){ref-type="ref"}).

3. RESULTS {#mgg3971-sec-0013}
==========

3.1. Identification of DEMs {#mgg3971-sec-0014}
---------------------------

As presented in Figure [1](#mgg3971-fig-0001){ref-type="fig"}, nine upregulated and nine downregulated DEMs were identified in primary human hepatocytes with AFB1 exposure compared to those without. Moreover, heatmap of identified DEMs was presented in Figure [2](#mgg3971-fig-0002){ref-type="fig"}. We showed that the samples with or without AFB1 treatment were clearly divided into two groups, suggesting the reliability to analyze DEMs in the following experiments.

![Volcano Plot of differentially expressed miRNAs. Abscissa axis indicates log2 (Fold Change). Vertical axis indicates −log10 (*p* value). Green represents downregulated miRNAs. Red represents upregulated miRNAs. Black indicates no significantly differentially expressed miRNAs. miRNAs, microRNAs](MGG3-7-e971-g001){#mgg3971-fig-0001}

![Heat map of differentially expressed miRNAs. Changes in *p* \< .05 and \|log2 fold‐change\| ≥ 1.5 are illustrated by a heat map. miRNAs, microRNAs](MGG3-7-e971-g002){#mgg3971-fig-0002}

3.2. Target genes of DEMs {#mgg3971-sec-0015}
-------------------------

Five miRNA target prediction algorithms were employed to analyze potential targets of these identified DEMs. Targets predicted by at least 3 algorithms were selected for followingly analyses. Tables [1](#mgg3971-tbl-0001){ref-type="table"} and [2](#mgg3971-tbl-0002){ref-type="table"} displayed the targets that contained the most and second‐most binding sites for upregulated and downregulated DEMs, respectively.

###### 

Targets contain the most and second‐most binding site for upregulated DEMs

  Target     miRNA list
  ---------- ----------------------------------------------------------------
  KMT2A      hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p
  ANKRD52    hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐199a‐3p
  NAP1L1     hsa‐miR‐222‐3p, hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p
  NAA25      hsa‐miR‐222‐3p, hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p
  RFX7       hsa‐miR‐222‐3p, hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p
  CTDSPL2    hsa‐miR‐222‐3p, hsa‐miR‐30a‐3p, hsa‐miR‐532‐5p
  PPP3R1     hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p
  REV1       hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p
  BRWD1      hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p
  ARF4       hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p
  FOXP1      hsa‐miR‐222‐3p, hsa‐miR‐34b‐5p, hsa‐miR‐34a‐5p
  SNX4       hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐34a‐5p
  MITF       hsa‐miR‐222‐3p, hsa‐miR‐96‐5p, hsa‐miR‐34b‐5p
  RNF4       hsa‐miR‐222‐3p, hsa‐miR‐34b‐5p, hsa‐miR‐34a‐5p
  PURA       hsa‐miR‐222‐3p, hsa‐miR‐199a‐3p, hsa‐miR‐532‐5p
  UBE2J1     hsa‐miR‐222‐3p, hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p
  QKI        hsa‐miR‐222‐3p, hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p
  CAMK2N1    hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p, hsa‐miR‐532‐5p
  RARG       hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p, hsa‐miR‐34a‐5p
  ZDHHC17    hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p, hsa‐miR‐34a‐5p
  ARPP19     hsa‐miR‐96‐5p, hsa‐miR‐532‐5p, hsa‐miR‐1275
  VAT1       hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p, hsa‐miR‐34a‐5p
  MAPRE1     hsa‐miR‐96‐5p, hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p
  FAM49B     hsa‐miR‐96‐5p, hsa‐miR‐199a‐3p, hsa‐miR‐34b‐5p
  ARID4B     hsa‐miR‐30a‐3p, hsa‐miR‐34b‐5p, hsa‐miR‐34a‐5p
  SH3PXD2A   hsa‐miR‐30a‐3p, hsa‐miR‐532‐5p, hsa‐miR‐1275
  TAOK1      hsa‐miR‐30a‐3p, hsa‐miR‐199a‐3p, hsa‐miR‐1275
  NOTCH1     hsa‐miR‐30a‐3p, hsa‐miR‐34b‐5p, hsa‐miR‐34a‐5p

Abbreviation: DEMs, differentially expressed microRNAs.

John Wiley & Sons, Ltd

###### 

Targets contain the most and second‐most binding site for downregulated DEMs

  Target    miRNA list
  --------- --------------------------------------------------------------------------
  TNRC6B    hsa‐miR‐1260b, hsa‐miR‐513b, hsa‐miR‐4286, hsa‐miR‐1228‐3p, hsa‐miR‐4257
  ZFHX4     hsa‐miR‐6085, hsa‐miR‐513b, hsa‐miR‐1228‐3p, hsa‐miR‐4257
  POU2F1    hsa‐miR‐1260b, hsa‐miR‐4286, hsa‐miR‐1228‐3p, hsa‐miR‐4257
  TFDP2     hsa‐miR‐1260b, hsa‐miR‐5100, hsa‐miR‐4286, hsa‐miR‐1260a
  FAM122B   hsa‐miR‐1260b, hsa‐miR‐513b, hsa‐miR‐4286, hsa‐miR‐505‐3p
  NUFIP2    hsa‐miR‐1260b, hsa‐miR‐5100, hsa‐miR‐1228‐3p, hsa‐miR‐1260a
  FAM222B   hsa‐miR‐6085, hsa‐miR‐5100, hsa‐miR‐4286, hsa‐miR‐1228‐3p
  TBL1XR1   hsa‐miR‐5100, hsa‐miR‐513b, hsa‐miR‐4286, hsa‐miR‐4257
  CELF1     hsa‐miR‐513b, hsa‐miR‐4286, hsa‐miR‐505‐3p, hsa‐miR‐4257

Abbreviation: DEMs, differentially expressed microRNAs.

John Wiley & Sons, Ltd

3.3. Functional analyses of the upregulated or downregulated DEMs {#mgg3971-sec-0016}
-----------------------------------------------------------------

Gene ontology analysis including BP, CC and MF terms for the targets of upregulated or downregulated DEMs were performed to understand the roles of these DEMs. As displayed in Tables [3](#mgg3971-tbl-0003){ref-type="table"} and [4](#mgg3971-tbl-0004){ref-type="table"}, our results revealed that these DEMs have crucial roles in regulating gene expression and cell behaviors. KEGG pathway enrichment analysis in Figure [3](#mgg3971-fig-0003){ref-type="fig"}a,b revealed that the most enriched pathways were related to cancer development.

###### 

GO analysis of targets of the upregulated DEMs

  Category             ID                                                                                                              Description                                                            Count      *p* value
  -------------------- --------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------- ---------- -----------
  Biological process   GO:0045944                                                                                                      Positive regulation of transcription from RNA polymerase II promoter   174        5.08E‐22
  GO:0000122           Negative regulation of transcription from RNA polymerase II promoter                                            121                                                                    1.66E‐13   
  GO:0045893           Positive regulation of transcription, DNA‐templated                                                             94                                                                     1.00E‐12   
  GO:0006366           Transcription from RNA polymerase II promoter                                                                   91                                                                     1.22E‐11   
  GO:0045892           Negative regulation of transcription, DNA‐templated                                                             80                                                                     2.79E‐08   
  Molecular function   GO:0005515                                                                                                      Protein binding                                                        934        3.94E‐29
  GO:0003700           Transcription factor activity, sequence‐specific DNA binding                                                    142                                                                    1.69E‐11   
  GO:0001077           Transcriptional activator activity, RNA polymerase II core promoter proximal region sequence‐specific binding   49                                                                     6.02E‐09   
  GO:0000978           RNA polymerase II core promoter proximal region sequence‐specific DNA binding                                   64                                                                     8.19E‐09   
  GO:0043565           Sequence‐specific DNA binding                                                                                   81                                                                     5.53E‐08   
  Cellular component   GO:0005654                                                                                                      Nucleoplasm                                                            351        1.12E‐19
  GO:0005737           Cytoplasm                                                                                                       563                                                                    1.53E‐16   
  GO:0005634           Nucleus                                                                                                         579                                                                    1.72E‐16   
  GO:0005829           Cytosol                                                                                                         372                                                                    1.52E‐12   
  GO:0016020           Membrane                                                                                                        266                                                                    2.97E‐12   

Abbreviations: DEMs, differentially expressed microRNAs; GO, gene ontology.

John Wiley & Sons, Ltd

###### 

GO analysis of targets of the downregulated DEMs

  Category             ID                                         Description                                                    Count      *p* value
  -------------------- ------------------------------------------ -------------------------------------------------------------- ---------- -----------
  Biological process   GO:0050789                                 Regulation of biological process                               1751       3.20E‐14
  GO:0032502           Developmental process                      971                                                            2.54E‐12   
  GO:0065007           Biological regulation                      1823                                                           4.59E‐12   
  GO:0008152           Metabolic process                          1739                                                           1.54E‐09   
  GO:0009987           Cellular process                           2,326                                                          2.36E‐08   
  Molecular function   GO:0003700                                 Transcription factor activity, sequence‐specific DNA binding   211        2.91E‐10
  GO:0005515           Protein binding                            1,418                                                          1.46E‐09   
  GO:0003677           DNA binding                                329                                                            2.10E‐09   
  GO:0046872           Metal ion binding                          371                                                            5.25E‐06   
  GO:0,004,674         Protein serine/threonine kinase activity   87                                                             9.51E‐06   
  Cellular component   GO:0005654                                 Nucleoplasm                                                    513        2.50E‐10
  GO:0005634           Nucleus                                    912                                                            2.98E‐09   
  GO:0005737           Cytoplasm                                  861                                                            6.78E‐07   
  GO:0030054           Cell junction                              102                                                            6.97E‐06   
  GO:0045202           Synapse                                    47                                                             6.87E‐05   

Abbreviations: DEMs, differentially expressed microRNAs; GO, gene ontology.

John Wiley & Sons, Ltd

![Bubble chart of KEGG pathway enrichment analyses for (a) Upregulated DEMs and (b) downregulated DEMs. Different bubble color represents *p* value. Red indicates strong significance. Bubble size indicates gene numbers enriched in pathway. DEMs, differentially expressed microRNAs; KEGG, Kyoto Encyclopedia of Genes and Genomes](MGG3-7-e971-g003){#mgg3971-fig-0003}

3.4. Validation of DEMs expression in HCC using StarBase {#mgg3971-sec-0017}
--------------------------------------------------------

Next, we validated the expression of the DEMs identified in HCC. As presented in Figure [4](#mgg3971-fig-0004){ref-type="fig"}, the expression pattern of *hsa‐MIR‐505‐3p*, *hsa‐MIR‐1228‐3p*, *hsa‐MIR‐4286*, and *hsa‐MIR‐5100* of the nine downregulated DEMs was similar to the GEO dataset. For the nine upregulated DEMs, we found that all of them exhibited a similar expression trend in HCC as compared with the GEO dataset (Figure [5](#mgg3971-fig-0005){ref-type="fig"}).

![Validation of the expression pattern of downregulated DEMs in StarBase. DEMs, differentially expressed microRNAs](MGG3-7-e971-g004){#mgg3971-fig-0004}

![Validation of the expression pattern of upregulated DEMs in StarBase. DEMs, differentially expressed microRNAs](MGG3-7-e971-g005){#mgg3971-fig-0005}

3.5. Regulatory network analysis {#mgg3971-sec-0018}
--------------------------------

We were interested to identify miRNA‐mRNA networks after AFB1 exposure. Hence, three KEGG pathways related to cancer initiation were selected after pathway enrichment analyses. Three KEGG pathways including miRNAs in cancer, Pathways in cancer, and PI3K‐Akt signaling pathway for upregulated DEMs were selected and 13 overlapping genes were identified for following analyses (Figure [6](#mgg3971-fig-0006){ref-type="fig"}a). The expression of these 13 genes in HCC was validated in StarBase, and 10 of them were found to be abnormally expressed (Figure [6](#mgg3971-fig-0006){ref-type="fig"}b). Similarly, the pathways including Pathways in cancer, Ras signaling pathway, and VEGF signaling pathway for downregulated DEMs were analyzed with nine genes identified as shown in Figure [7](#mgg3971-fig-0007){ref-type="fig"}a. Also, we confirmed the expression of these 9 genes in HCC using Starbase. We found 6 (MAPK1 (176948), NRAS (164790), PIK3R3 (606076), PLCG1 (172420), PRKCA (176960), and PRKCB (176970)) of them were indeed elevated expresion in HCC (Figure [7](#mgg3971-fig-0007){ref-type="fig"}b). Based on these results, we further established the miRNA‐mRNA regulatory network for upregulated DEMs (Figure [8](#mgg3971-fig-0008){ref-type="fig"}a) and downregulated DEMs (Figure [8](#mgg3971-fig-0008){ref-type="fig"}b). As shown in Figure [8](#mgg3971-fig-0008){ref-type="fig"}a, *hsa‐MIR‐96‐5p* (611606) targeted the largest number of genes in the network. Meanwhile, we found only one downregulated miRNA, *hsa‐MIR‐4286* in Figure [8](#mgg3971-fig-0008){ref-type="fig"}b.

![Identification of genes related to HCC progression for upregulated DEMs. (a) Venn diagram indicated intersection of three pathways associated with onset of HCC for the target genes of upregulated DEMs. (b) Validation of the overlapping gene of these three pathways using StarBase. DEMs, differentially expressed microRNAs; HCC, hepatocellular carcinoma](MGG3-7-e971-g006){#mgg3971-fig-0006}

![Identification of genes related to HCC progression for downregulated DEMs. (a) Venn diagram indicated intersection of three pathways associated with onset of HCC for the target genes of downregulated DEMs. (b) Validation of the overlapping gene of these three pathways using StarBase. DEMs: differentially expressed microRNAs; HCC, hepatocellular carcinoma](MGG3-7-e971-g007){#mgg3971-fig-0007}

![miRNA‐mRNA regulatory network regarding AFB1‐induced onset of HCC. (a) Upregulated DEMs and (b) downregulated DEMs. AFB1, Aflatoxin B1; DEMs, differentially expressed microRNAs; HCC, hepatocellular carcinoma; miRNA, microRNA; mRNA, message RNA](MGG3-7-e971-g008){#mgg3971-fig-0008}

4. DISCUSSION {#mgg3971-sec-0019}
=============

Aflatoxin B1 is a highly toxic reagent produced by *Aspergillus flavus* and the exposure to AFB1 is reported to account for the initiation of approximately 4%--28% of all HCC cases (Liu & Wu, [2010](#mgg3971-bib-0019){ref-type="ref"}). Therefore, detection of early fingerprints after AFB1 exposure may help us to prevent the cell development into HCC (Fedeles, Chawanthayatham, Croy, Wogan, & Essigmann, [2017](#mgg3971-bib-0009){ref-type="ref"}). It was well‐recognized that miRNAs can regulate almose all cellular processes. Therefore, we hypothesized that miRNAs expression may also be altered in AFB1 treated cells. Importantly, studies comprehensively investigating the connection between miRNAs and AFB1 treatment are still lacking.

In this study, a miRNA expression profile dataset that contains data from primary human hepatocytes treated with AFB1 for 5 days and then subjected to 3 days wash‐out period was used to investigate the changed miRNAs after AFB1 withdraw. A total of 18 DEMs including nine upregulated DEMs and nine downregulated DEMs were identified. After targets prediction for these identified DEMs, we analyzed the biological functions using GO annotation and KEGG pathway enrichment methods. We found that the pathways of these genes involved were significantly associated with human cancer progression, which indicated that AFB1 exposure will indeed activate the development of cancers. On the basis of these analyses results, we constructed the miRNA‐mRNA regulatory network to help us understand the mechanisms related to HCC onset after AFB1 exposure. *hsa‐miR‐96‐5p* in the upregulated DEMs associated miRNA‐mRNA network has the largest target numbers. *hsa‐miR‐34a* was previously reported to correlate with liver tumorigenesis after AFB1 exposure (Zhu et al., [2015](#mgg3971-bib-0027){ref-type="ref"}). Furthermore, *hsa‐miR‐96‐5p*, *hsa‐MIR‐30a‐5p* (612326), *hsa‐MIR‐199a‐3p* (610719), and *hsa‐MIR‐222‐3p* (300569) were previously reported to be associated with HCC progression (Callegari et al., [2018](#mgg3971-bib-0005){ref-type="ref"}; de Conti et al., [2017](#mgg3971-bib-0008){ref-type="ref"}; Iwai et al., [2018](#mgg3971-bib-0013){ref-type="ref"}; Zhang, Liu, Zhang, & Liu, [2017](#mgg3971-bib-0026){ref-type="ref"}). However, the role of *hsa‐MIR‐34b‐5p* (611374) in HCC has not been reported to date and therefore our study implied that *hsa‐MIR‐34b‐5p* may be related to HCC onset. For the regulatory network constructed by downregulated DEMs, we have noted that the role of *hsa‐MIR‐4286* was not reported to be associated with HCC previously. Therefore, it deserves to be investigated in the future.

This work established miRNA‐mRNA regulatory networks related to the HCC onset by comprehensive bioinformatic analyses. The limitation in this work was that the predicted miRNA‐mRNA link was not experimentally validated, which need further investigations. Hence, future investigations on in vitro cell lines or in vivo animal models are required to validate the prediction results.

In summary, our in‐silico analyses results indicated miRNA‐mRNA connections contributing to the HCC onset after AFB1 exposure. We hope that our results can accelerate the process of tackling the AFB1‐induced onset of HCC.
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